Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
miRNA signature associated with R-CHOP refractoriness in patients diagnosed with diffuse large B cell lymphoma.
Fajardo-Ramirez OR, Villela L, Campa-Carranza JN, Perez-Maya AA, Borrego-Soto G, Wah-Suarez MI, Rodríguez-Sánchez IP, Zapata-Morin PA, Ortiz-Lopez R, Treviño VM, Garcia-Magariño M, Marino-Martinez IA. Fajardo-Ramirez OR, et al. Among authors: villela l. Noncoding RNA Res. 2020 Oct 10;5(4):185-190. doi: 10.1016/j.ncrna.2020.10.001. eCollection 2020 Dec. Noncoding RNA Res. 2020. PMID: 33134613 Free PMC article.
A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL).
Beltrán BE, Villela L, Torres MA, Otero V, Fiad L, Peña C, Cabrera ME, León P, Idrobo H, Castro DA, Paredes S, Perdomo I, Abello V, Rojas C, Ramirez-Ibargüen A, Candelaria M, Pérez-Jacobo F, Montaño-Figueroa E, Best C, Goméz-De Leon A, Gómez-Almaguer D, Ruiz-Argüelles G, Hernández-Hernández J, Malpica L, Sotomayor EM, Castillo JJ; Latin American Group of Lymphoproliferative Disorders (Grupo de Estudio Latinoamericano de Linfoproliferativos [GELL]). Beltrán BE, et al. Among authors: villela l. Clin Lymphoma Myeloma Leuk. 2020 Oct;20(10):637-646. doi: 10.1016/j.clml.2020.04.016. Epub 2020 May 4. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32513598
Real-world data on the clinical features, therapy patterns, and outcomes of older adults with diffuse large B-cell lymphoma in Latin America: A study from the Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL).
Candelaria M, Villela L, Oñate-Ocana LF, Beltran B, Torres-Viera M, Oliver A, Idrobo H, Perez-Jacobo F, Perini G, Peña C, Korin L, Castro D, Irigoyen V, Paredes S, Hernandez-Hernandez JA, Colunga P, Gomez-Almaguer D, Ruiz-Argüelles G, Otañez M, Castillo JJ, Malpica L. Candelaria M, et al. Among authors: villela l. J Geriatr Oncol. 2025 Jan;16(1):102160. doi: 10.1016/j.jgo.2024.102160. Epub 2024 Nov 30. J Geriatr Oncol. 2025. PMID: 39615249
Discriminant analysis and machine learning approach for evaluating and improving the performance of immunohistochemical algorithms for COO classification of DLBCL.
Perfecto-Avalos Y, Garcia-Gonzalez A, Hernandez-Reynoso A, Sánchez-Ante G, Ortiz-Hidalgo C, Scott SP, Fuentes-Aguilar RQ, Diaz-Dominguez R, León-Martínez G, Velasco-Vales V, Cárdenas-Escudero MA, Hernández-Hernández JA, Santos A, Borbolla-Escoboza JR, Villela L. Perfecto-Avalos Y, et al. Among authors: villela l. J Transl Med. 2019 Jun 11;17(1):198. doi: 10.1186/s12967-019-1951-y. J Transl Med. 2019. PMID: 31185999 Free PMC article.
Non-Hodgkin lymphoma treatment in middle-income countries in Latin America: perspective of the Latin American Study Group of Lymphoproliferative Disorders [Grupo de Estudio de Linfoproliferativos de Latino América (GELL)].
Villela L, Torre-Viera M, Idrobo-Quintero H, Beltran BE; Grupo de Estudio de Linfoproliferativos de Latinoamérica (GELL). Villela L, et al. Hematology. 2022 Dec;27(1):1208-1216. doi: 10.1080/16078454.2022.2141960. Hematology. 2022. PMID: 36326296 Free article.
[National guidelines of diagnosis and treatment of the non-Hodgkin lymphoma].
Candelaria M, Cervera-Ceballos E, Meneses-García A, Avilés-Salas A, Lome-Maldonado C, Zárate-Osorno A, Ortiz-Hidalgo C, Rodríguez-Moguel L, Quiñónez-Urrego EE, Ramos-Salazar P, Romero-Guadarrama MB, Lara-Torres C, Ramírez-Aceves R, López-Navarro O, Rivas-Vera S, Díaz-Meneses IE, Estrada-Lobato E, Cervera-Ceballos J, Rojas-Marín CE, Hernández-Rodriguez JM, Pérez-López B, Gómez-Almaguer D, Altamirano-Ley J, Baz P, Valero-Saldaña LM, Navarrete-Herrera JR, Torres-Salgado FG, Solano-Murillo P, Nambo-Lucio Mde J, Rivas-Llamas R, Aquino-Salgado JL, Avila-Arreguín EV, Cortês-Esteban P, Chongo-Alfaro ML, Pérez-Ramírez Ode J, Toledano-Cuevas DV, Lobato-Mendizábal E, Martínez-Ramírez MA, Morales-Maravilla A, Sosa-Camas RE, Agreda-Vásquez GP, Camacho-Hernández A, Aguayo-González A, Espinoza-Zamora JR, Sánchez-Guerrero SA, Lozano-Zavaleta V, Selva-Pallares JE, Hernádez-Rodríguez JM, Cardiel-Silva M, Castillo-Rivera MH, Villela L, Loarca-Piña LM, Zurita-Martínez H, Graham-Casassus J, Azaola-Espinosa P, Silva-López S, Armenta-San Sebastián JA, Mijangos-Huesca F, Pérez-Osorio JE, Aldaco-Sarvide F, Castellanos G, Ramírez-Ibarguen AF, Zapata-Canto N, Labardini-Méndez JR. Candelaria M, et al. Among authors: villela l. Rev Invest Clin. 2013 Jun;65 Suppl 2:s5-27. Rev Invest Clin. 2013. PMID: 24459777 Spanish.
88 results